Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Acadia Pharmaceuticals (ACAD) Q2 2014 Earnings
ACAD
+0.17%
6
May
Confirmed
Q3 2013
Q4 2013
Q1 2014
Q2 2014
-0.19
-0.16
-0.14
-0.11
Details
Expected EPS
-0.14
Actual EPS
-0.19
Surprise EPS
-0.05
Surprise Percent
+35.71%
Description
Acadia Pharmaceuticals (ACAD) has reported earnings of -0.19 per share for Q2 2014.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login